Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 12/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23067909 | 0.76 | ADRA1D (0.50) | ADRA1DADRA1AADRA1BHTR1A | |
| SCHEMBL12204109 | 0.75 | OPRL1 (0.50) | ALDH1A1KDM4EOPRL1 | |
| SCHEMBL23074693 | 0.74 | ADRA1D (0.40) | ALDH1A1ADRA1DADRA1AADRA1B | |
| SCHEMBL29985588 | 0.74 | KDM4E (0.67) | ALDH1A1KDM4ECYP1A2CYP2D6CYP2C19 | |
| SCHEMBL23067907 | 0.73 | HTR1B (0.49) | KDM4EADRA1DADRA1AADRA1B | |
| SCHEMBL23074689 | 0.72 | ADRA1D (0.39) | ALDH1A1ADRA1D | |
| SCHEMBL29985842 | 0.72 | KDM4E (0.68) | ALDH1A1KDM4ECYP1A2CYP2D6CYP2C19 | |
| SCHEMBL29045820 | 0.71 | FOXM1 (0.61) | ALDH1A1KDM4ECYP1A2CYP2D6CYP2C19 | |
| SCHEMBL26269093 | 0.71 | PABPC1 (0.57) | ALDH1A1KDM4EOPRL1CYP2D6 | |
| SCHEMBL12204097 | 0.70 | OPRL1 (0.49) | ALDH1A1KDM4EOPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | BIO-RAD LABORATORIES, INC. | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | ABCG2, SLC7A1, MSR1 | ALDH1A1 4738/4885KDM4E 3830/4885ADRA1D 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.